| Literature DB >> 35886420 |
Jana Nele Arnold1,2, Nils Gundlach3, Irina Böckelmann2, Stefan Sammito2,4.
Abstract
Vaccination is one of the most effective medical measures for preventing infectious diseases. Even though there are recommendations for specific occupational groups that have an increased risk of infection, e.g., armed forces personnel, there are gaps in the vaccination rates of this personal. We conducted a randomised and controlled cohort study to examine whether a computerised reminder system would increase the vaccination rates of active soldiers over a period of twelve months. A total of 506 soldiers with a mean age of 27.7 ± 6.5 years (experimental group (EG)) and 27.9 ± 6.3 years (control group (CG)) were included in our study. Only 26.2% of the EG and 31.3% of the CG had received the required vaccinations at the beginning of our study. The vaccination rates for influenza (50.5% and 49.1%) and tick-borne encephalitis (57.1% and 60.7%) were particularly low, for measles, mumps, and rubella they were high (94.3% and 97.8%). A highly significant increase (p < 0.001) in vaccination rates was observed for both groups during our study. The results revealed considerable vaccination gaps among German armed forces soldiers. Despite a highly significant increase in vaccination rates during the study, there is still a clear need for action.Entities:
Keywords: infectious diseases; military; prevention; vaccination rates; vaccinations
Mesh:
Substances:
Year: 2022 PMID: 35886420 PMCID: PMC9324678 DOI: 10.3390/ijerph19148568
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Figure 1Flow chart on participant numbers (n) with exclusion criteria, subsequent randomisation and calculation of mean age.
Vaccination rates (absolute numbers) of the experimental (EG) and control groups (CG) at T0 and the results of the bivariate analysis by means of the chi-squared test. Overall protection is defined as a full vaccination status against all nine immunisations listed above. MMR = measles, mumps, rubella, TBE = tick-borne encephalitis.
| Vaccination Rate EG (n = 210) | Vaccination Rate CG | Chi2 Test | |
|---|---|---|---|
| Tetanus | 84.8% (178) | 91.1% (204) | 0.054 |
| Diphtheria | 85.2% (179) | 91.1% (204) | 0.073 |
| Polio | 81.4% (171) | 89.3% (200) |
|
| Pertussis | 88.6% (186) | 87.5% (196) | 0.769 |
| MMR | 94.3% (198) | 97.8% (219) | 0.082 |
| Hepatitis A | 80.5% (169) | 83.0% (186) | 0.535 |
| Hepatitis B | 77.1% (162) | 79.0% (177) | 0.644 |
| TBE | 57.1% (120) | 60.7% (136) | 0.494 |
| Influenza | 50.5% (106) | 49.1% (110) | 0.848 |
| Overall protection | 26.2% (55) | 31.3% (70) | 0.289 |
Vaccination rates (absolute numbers) of the experimental (EG) and control groups (CG) at T0 and T4 as well as absolute increases in vaccination rates during the study. Overall protection is defined as a full vaccination status against all nine immunisations listed above. MMR = measles, mumps, rubella, TBE = tick-borne encephalitis.
| Vaccination Rate EG | Vaccination Rate CG | |||||
|---|---|---|---|---|---|---|
| T0 | T4 | Δ (T0–T4) | T0 | T4 | Δ (T0–T4) | |
| Tetanus | 84.8% (178) | 90.5% (190) | +5.7% | 91.1% (204) | 96.0% (215) | +4.9% |
| Diphtheria | 85.2% (179) | 90.5% (190) | +5.3% | 91.1% (204) | 96.0% (215) | +4.9% |
| Polio | 81.4% (171) | 88.1% (185) | +6.7% | 89.3% (200) | 95.1% (213) | +5.8% |
| Pertussis | 88.6% (186) | 95.7% (201) | +7.1% | 87.5% (196) | 92.0% (206) | +4.5% |
| MMR | 94.3% (198) | 97.1% (204) | +2.8% | 97.8% (219) | 99.1% (222) | +1.3% |
| Hepatitis A | 80.5% (169) | 92.4% (194) | +11.9% | 83.0% (186) | 95.5% (214) | +12.5% |
| Hepatitis B | 77.1% (162) | 90.5% (190) | +13.4% | 79.0% (177) | 91.5% (205) | +12.5% |
| TBE | 57.1% (120) | 77.1% (162) | +20.0% | 60.7% (136) | 78.1% (175) | +17.4% |
| Influenza | 50.5% (106) | 63.3% (133) | +12.8% | 49.1% (110) | 64.7% (145) | +15.6% |
| Overall protection | 26.2% (55) | 47.1% (99) | +20.9% | 31.3% (70) | 48.2% (108) | +16.9% |
Figure 2Development of full immunisation against the diseases applicable to assistance and disaster relief operations at home (tetanus, diphtheria, polio, pertussis, measles, mumps, rubella, hepatitis A, hepatitis B, tick-borne encephalitis, influenza) during the study period, X-axes show the number of full immunisations, maximum 9 (A = vaccinations at beginning of the study (T0), B = vaccinations at the end of the study (T4)).
Results of the Friedman test for significant changes in vaccination rates from T0 to T4 and the Wilcoxon tests between the various time points.
| pFriedman T1, T2, T3 and T4 | pWilcoxon | pWilcoxon | pWilcoxon | pWilcoxon | |
|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| 0.077 |
|
Results of the chi2-test for significant changes between the two groups for T0–T4.
| T0 | T1 | T2 | T3 | T4 | |
|---|---|---|---|---|---|
|
| 0.479 | 0.979 | 0.387 | 0.233 | 0.104 |
|
| 0.124 | 0.572 | 0.568 | 0.874 | 0.662 |